Investor Hecht Peter M
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Hecht Peter M . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-03-28 13D/A CYCN / Cyclerion Therapeutics, Inc. 840,899 1,028,086
2023-12-05 13D/A CYCN / Cyclerion Therapeutics, Inc. 518,464 840,899
2023-05-23 13D/A CYCN / Cyclerion Therapeutics, Inc. 10,369,298 518,464
2023-05-12 13D/A CYCN / Cyclerion Therapeutics, Inc. 4,219,658 10,369,298
2023-04-03 13D/A CYCN / Cyclerion Therapeutics, Inc. 4,200,052 4,219,658
2022-11-21 13D/A CYCN / Cyclerion Therapeutics, Inc. 3,596,668 4,200,052
2021-06-07 13D/A CYCN / Cyclerion Therapeutics, Inc. 2,773,498 3,596,668
2021-05-14 13D CYCN / Cyclerion Therapeutics, Inc. 2,773,498